Compounded Bioidentical Hormone Therapy Market Size

Compounded Bioidentical Hormone Therapy Market size is expected to register around 5.2% CAGR during the forecast period i.e., between 2024-2036. The compounded bioidentical hormone therapy utilizes processed hormones to help people in regulating the hormonal imbalances. It is estimated that around 80% women suffer from hormonal imbalance worldwide. The global compounded bioidentical hormone market is estimated to expand at a rapid rate over the forecast period on account of the increasing population of women with hormonal imbalances. Furthermore, compounded bioidentical hormone therapy can be used to treat conditions, such as, thyroid disorders, insulin resistance, osteoporosis, and fibromyalgia. As the number of patients is increasing worldwide, scientists are expeditiously researching the remedies, such as, bioidentical hormones. Additionally, menopause in women causes night sweats, insomnia, and hot flashes, which can be prevented by using compounded bioidentical hormone therapy. Owing to its various benefits, the global market is estimated to boost over the forecast period.